Poor neutralization and rapid decay of antibodies to SARS-CoV-2 variants in vaccinated dialysis patients

Patients on dialysis are at risk of severe course of SARS-CoV-2 infection. Understanding the neutralizing activity and coverage of SARS-CoV-2 variants of vaccine-elicited antibodies is required to guide prophylactic and therapeutic COVID-19 interventions in this frail population. By analyzing plasma...

Descripción completa

Detalles Bibliográficos
Autores principales: Bassi, Jessica, Giannini, Olivier, Silacci-Fregni, Chiara, Pertusini, Laura, Hitz, Paolo, Terrot, Tatiana, Franzosi, Yves, Muoio, Francesco, Saliba, Christian, Meury, Marcel, Dellota, Exequiel A., Dillen, Josh R., Hernandez, Patrick, Czudnochowski, Nadine, Cameroni, Elisabetta, Beria, Nicola, Ventresca, Mariangela, Badellino, Alberto, Lavorato-Hadjeres, Soraya, Lecchi, Elisabetta, Bonora, Tecla, Mattiolo, Matteo, Trinci, Guido, Garzoni, Daniela, Bonforte, Giuseppe, Forni-Ogna, Valentina, Giunzioni, Davide, Berwert, Lorenzo, Gupta, Ravindra K., Ferrari, Paolo, Ceschi, Alessandro, Cippà, Pietro, Corti, Davide, Lanzavecchia, Antonio, Piccoli, Luca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830698/
https://www.ncbi.nlm.nih.gov/pubmed/35143540
http://dx.doi.org/10.1371/journal.pone.0263328

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830698/
https://www.ncbi.nlm.nih.gov/pubmed/35143540
http://dx.doi.org/10.1371/journal.pone.0263328

Ejemplares similares